Delivery Order SPE2DR25D1053-SPE2DR26FT504
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Lazicluze 240 mg tablets (30-count units) with a ceiling value of $12,446.16. This firm fixed-price delivery order, with an ultimate completion date of July 9, 2025, represents a non-competitive set-aside transaction executed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major...
- The Defense Logistics Agency awarded a $12,449.18 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Lazcluze 80 mg, with performance at the company's headquarters in Conshohocken, Pennsylvania, and completion targeted for September 30, 2025. This non-set-aside contract was competitively awarded on September 9, 2025, under firm fixed pricing terms and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order valued at $12,446.16 to AmerisourceBergen Drug Corp for the supply of Lazcluze 240 mg tablets (30-count units) on July 16, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $12.4K delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Lazcluze 80 mg tablets, with an ultimate completion date of June 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is...
- This delivery order, awarded on September 24, 2025, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, provides for the supply of Lazcluze 240 mg tablets (30-count units) to support federal medical procurement needs. The $12,446.16 firm fixed-price order is funded by the Defense Logistics Agency's Medical Supply Chain and carries an ultimate completion date of October 16, 2025. The contract represents a non-competitive, competitively...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $12,446.16 firm fixed-price delivery order is for the supply of LAZCLUZE 240 MG TABLET 30S, a medical product, with a completion date of July 10, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,446.16 Firm Fixed Price delivery order contract is for the supply of 4568726454 ! LAZCLUZE 240 MG TABLET 30S. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the place of performance is Conshohocken, Pennsylvania. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,657.44 firm-fixed-price delivery order is for the supply of 200 milliliter bottles of a 10 milligram per milliliter solution of the medication lacosamide. The award is not set aside for any particular business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order valued at $2,834.32 to AmerisourceBergen Drug Corp for the supply of Wezlana 130 mg/26 mL vials on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a pharmaceutical supply delivery to support federal medical procurement needs. The order is being fulfilled from AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $27,841.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for 4569617740 ORSERDU 345 mg tablets (30-count units) on September 28, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside competitive award leverages AmerisourceBergen's indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.9 million through December 2026. The vendor, headquartered in Conshohocken,...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT504Delivery Order
The Defense Logistics Agency awarded a $12,052.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lazicluze 80 mg tablets (60-count units) with a completion deadline of November 24, 2025. This non-set-aside contract was competitively awarded on October 31, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This award is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion master contract running through December 2026 that authorizes the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs. As a leading pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of delivery orders covering brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 10/31/25 |